The FIB-4 model was originally developed to predict liver fibrosis in patients with HIV/HCV coinfection, using routine tests (AST, ALT, platelets) [51]; nowadays, it is extensively used for the non-invasive estimation of the liver fibrosis in hepatitis B, hepatitis C, and FLD subjects. Here, GPT is linked to Hepatic fibrosis.